Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,963
Closed -$1.66M 8
2025
Q2
$1.66M Buy
5,963
+2,236
+60% +$633K 0.48% 55
2025
Q1
$1.16M Buy
3,727
+72
+2% +$21.3K 0.27% 78
2024
Q4
$953K Buy
+3,655
New +$1.08M 0.22% 84
2021
Q1
Sell
-5,680
Closed -$1.35M 96
2020
Q4
$1.35M Sell
5,680
-377
-6% -$86.9K 0.8% 39
2020
Q3
$1.41M Buy
6,057
+118
+2% +$29.2K 0.88% 37
2020
Q2
$1.45M Buy
5,939
+73
+1% +$16.7K 0.99% 34
2020
Q1
$1.19M Buy
5,866
+652
+13% +$142K 1.15% 31
2019
Q4
$1.26M Buy
+5,214
New +$1.15M 1.11% 32

Other funds holding AMGN

DOHJ LLC's AMGN Position: Q3 2025 in Review

DOHJ LLC sold out of Amgen (AMGN) in Q3 2025, closing a stake of 5,963 shares — an estimated $1.66M sold.

DOHJ LLC first reported a position in AMGN in Q4 2019 and held it in 8 quarters. The position peaked at $1.66M in Q2 2025. 2,820 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • DOHJ LLC reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • DOHJ LLC sold 5,963 Amgen shares in Q3 2025, an estimated $1.66M.
  • DOHJ LLC first reported a position in Amgen in Q4 2019 and held it in 8 quarters.
  • DOHJ LLC's Amgen position peaked at $1.66M in Q2 2025.
  • 2,820 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on DOHJ LLC's 13F filing for Q3 2025.